145 related articles for article (PubMed ID: 34089473)
1. AMP hydrolysis reduction in blood plasma of breast cancer elderly patients after different treatments.
Gheler FV; Cappellari AR; Renck D; de Souza JB; de Melo RO; Moehlecke BZ; Moriguchi CA; Engroff P; Lambert APF; Rockenbach L; Morrone FB
Mol Cell Biochem; 2021 Oct; 476(10):3719-3727. PubMed ID: 34089473
[TBL] [Abstract][Full Text] [Related]
2. Hydrolysis of ATP, ADP, and AMP is increased in blood plasma of prostate cancer patients.
Gardani CFF; Cappellari AR; de Souza JB; da Silva BT; Engroff P; Moritz CEJ; Scholl JN; Battastini AMO; Figueiró F; Morrone FB
Purinergic Signal; 2019 Mar; 15(1):95-105. PubMed ID: 30644036
[TBL] [Abstract][Full Text] [Related]
3. Enzyme activity of circulating CD73 in human serum.
Morello S; Turiello R; Madonna G; Pinto A; Ascierto PA; Capone M
Methods Enzymol; 2019; 629():257-267. PubMed ID: 31727244
[TBL] [Abstract][Full Text] [Related]
4. Detection of CD39 and a Highly Glycosylated Isoform of Soluble CD73 in the Plasma of Patients with Cervical Cancer: Correlation with Disease Progression.
Muñóz-Godínez R; de Lourdes Mora-García M; Weiss-Steider B; Montesinos-Montesinos JJ; Del Carmen Aguilar-Lemarroy A; García-Rocha R; Hernández-Montes J; Azucena Don-López C; Ávila-Ibarra LR; Torres-Pineda DB; Molina-Castillo G; Chacón-Salinas R; Vallejo-Castillo L; Pérez-Tapia SM; Monroy-García A
Mediators Inflamm; 2020; 2020():1678780. PubMed ID: 33488292
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the extracellular catabolism of nucleotides are involved in the antiproliferative effect of quercetin in human bladder cancer T24 cells.
Rockenbach L; Bavaresco L; Fernandes Farias P; Cappellari AR; Barrios CH; Bueno Morrone F; Oliveira Battastini AM
Urol Oncol; 2013 Oct; 31(7):1204-11. PubMed ID: 22137869
[TBL] [Abstract][Full Text] [Related]
6. CD39 and CD73 in the aortic valve-biochemical and immunohistochemical analysis in valve cell populations and its changes in valve mineralization.
Kaniewska-Bednarczuk E; Kutryb-Zajac B; Sarathchandra P; Pelikant-Malecka I; Sielicka A; Piotrowska I; Slominska EM; Chester AH; Yacoub MH; Smolenski RT
Cardiovasc Pathol; 2018; 36():53-63. PubMed ID: 30056298
[TBL] [Abstract][Full Text] [Related]
7. Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy.
Turiello R; Capone M; Giannarelli D; Morretta E; Monti MC; Madonna G; Mallardo D; Festino L; Azzaro R; Levesque MP; Imhof L; Weide B; Amaral T; Chevrier M; Sucker A; Rutkowski P; Schadendorf D; Lebbe C; Luke JJ; Wistuba-Hamprecht K; Dummer R; Pinto A; Morello S; Ascierto PA
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33361405
[TBL] [Abstract][Full Text] [Related]
8. Enzymes that hydrolyze adenine nucleotides in platelets from breast cancer patients.
do Carmo Araújo M; Rocha JB; Morsch A; Zanin R; Bauchspiess R; Morsch VM; Schetinger MR
Biochim Biophys Acta; 2005 Jun; 1740(3):421-6. PubMed ID: 15949710
[TBL] [Abstract][Full Text] [Related]
9. Effect of high glucose levels in human platelet NTPDase and 5'-nucleotidase activities.
Lunkes GI; Lunkes DS; Leal D; Araújo Mdo C; Corrêa M; Becker L; Rosa CS; Morsch VM; Schetinger MR
Diabetes Res Clin Pract; 2008 Sep; 81(3):351-7. PubMed ID: 18644642
[TBL] [Abstract][Full Text] [Related]
10. Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis.
Jalkanen J; Yegutkin GG; Hollmén M; Aalto K; Kiviniemi T; Salomaa V; Jalkanen S; Hakovirta H
Circ Res; 2015 Mar; 116(7):1206-15. PubMed ID: 25645301
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of adenine nucleotides in human blood.
Coade SB; Pearson JD
Circ Res; 1989 Sep; 65(3):531-7. PubMed ID: 2548757
[TBL] [Abstract][Full Text] [Related]
12. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
[TBL] [Abstract][Full Text] [Related]
13. E-NTPDases and ecto-5'-nucleotidase expression profile in rat heart left ventricle and the extracellular nucleotide hydrolysis by their nerve terminal endings.
Rücker B; Almeida ME; Libermann TA; Zerbini LF; Wink MR; Sarkis JJ
Life Sci; 2008 Feb; 82(9-10):477-86. PubMed ID: 18201730
[TBL] [Abstract][Full Text] [Related]
14. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production.
Clayton A; Al-Taei S; Webber J; Mason MD; Tabi Z
J Immunol; 2011 Jul; 187(2):676-83. PubMed ID: 21677139
[TBL] [Abstract][Full Text] [Related]
15. CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.
Gao ZW; Wang HP; Lin F; Wang X; Long M; Zhang HZ; Dong K
BMC Cancer; 2017 Feb; 17(1):135. PubMed ID: 28202050
[TBL] [Abstract][Full Text] [Related]
16. Generation and Function of Non-cell-bound CD73 in Inflammation.
Schneider E; Rissiek A; Winzer R; Puig B; Rissiek B; Haag F; Mittrücker HW; Magnus T; Tolosa E
Front Immunol; 2019; 10():1729. PubMed ID: 31404305
[TBL] [Abstract][Full Text] [Related]
17. In vitro effect of homocysteine on nucleotide hydrolysis by blood serum from adult rats.
Böhmer AE; Pochmann D; Sarkis JJ
Chem Biol Interact; 2006 Mar; 160(2):159-64. PubMed ID: 16466706
[TBL] [Abstract][Full Text] [Related]
18. Time-course changes in ectonucleotidase activities during experimental autoimmune encephalomyelitis.
Lavrnja I; Bjelobaba I; Stojiljkovic M; Pekovic S; Mostarica-Stojkovic M; Stosic-Grujicic S; Nedeljkovic N
Neurochem Int; 2009 Sep; 55(4):193-8. PubMed ID: 19524108
[TBL] [Abstract][Full Text] [Related]
19. Extracellular 5'-nucleotidase (CD73) promotes human breast cancer cells growth through AKT/GSK-3β/β-catenin/cyclinD1 signaling pathway.
Yu J; Wang X; Lu Q; Wang J; Li L; Liao X; Zhu W; Lv L; Zhi X; Yu J; Jin Y; Zou Q; Ou Z; Liu X; Zhou P
Int J Cancer; 2018 Mar; 142(5):959-967. PubMed ID: 29047106
[TBL] [Abstract][Full Text] [Related]
20. CD73 expression as a potential marker of good prognosis in breast carcinoma.
Supernat A; Markiewicz A; Welnicka-Jaskiewicz M; Seroczynska B; Skokowski J; Sejda A; Szade J; Czapiewski P; Biernat W; Zaczek A
Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):103-7. PubMed ID: 22553809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
